companydata.dkcompanydata.dk

Turnbull Biotech ApS: Financial statements 2025

CVR: 43491938

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Turnbull Biotech ApS (CVR 43491938) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -71,508 and a net result of DKK -241,233 compared with DKK 166,587 the year before. Equity in the 2025 report amounted to DKK 251,823. The solvency ratio was 90.2%. The company had 1 employee in the financial year.

Gross Profit
DKK -71,508
Profit/Loss
DKK -241,233
Equity
DKK 251,823
Total Assets
DKK 279,295
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--72K-241K252K1
2024--51K167K493K0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Turnbull Biotech ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Turnbull Biotech ApS: The 2024 annual report is outJul 10, 2025

Turnbull Biotech ApS has published its annual report for 2024. Gross profit came to DKK -51,241, and the net result was DKK 166,587.

About Turnbull Biotech ApS

Turnbull Biotech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jordan Philip Turnbull. The company is owned by Jordan Philip Turnbull. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -71,508 and a net result of DKK -241,233 compared with DKK 166,587 the year before. Equity in the 2025 report amounted to DKK 251,823.

Source: annual report 2025, Danish Business Authority

Other financial years